The Neuropeptide Hormone Oxytocin in Eating Disorders
- PMID: 30178087
- PMCID: PMC6903388
- DOI: 10.1007/s11920-018-0957-0
The Neuropeptide Hormone Oxytocin in Eating Disorders
Abstract
Purpose of review: The neurohormone oxytocin (OXT) impacts food intake as well as cognitive, emotional, and social functioning-all of which are central to eating disorder (ED) pathology across the weight spectrum. Here, we review findings on endogenous OXT levels and their relationship to ED pathology, the impact of exogenous OXT on mechanisms that drive ED presentation and chronicity, and the potential role of genetic predispositions in the OXT-ED link.
Recent findings: Current findings suggest a role of the OXT system in the pathophysiology of anorexia nervosa. In individuals with bulimia nervosa, endogenous OXT levels were comparable to those of healthy controls, and exogenous OXT reduced food intake. Studies in other ED are lacking. However, genetic studies suggest a broad role of the OXT system in influencing ED pathology. Highlighting findings on why OXT represents a potential biomarker of and treatment target for ED, we advocate for a systematic research approach spanning the entire ED spectrum.
Keywords: Anorexia nervosa; Binge eating; Bulimia nervosa; Eating disorders; Food intake; Oxytocin.
Similar articles
-
Oxytocin and Eating Disorders: A Narrative Review on Emerging Findings and Perspectives.Curr Neuropharmacol. 2018;16(8):1111-1121. doi: 10.2174/1570159X15666171128143158. Curr Neuropharmacol. 2018. PMID: 29189166 Free PMC article. Review.
-
A scoping review and hypothetical framework about the interplay between oxytocin and eating disorders.Physiol Behav. 2025 Mar 1;290:114777. doi: 10.1016/j.physbeh.2024.114777. Epub 2024 Dec 6. Physiol Behav. 2025. PMID: 39647564
-
Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):132-142. doi: 10.1016/j.pnpbp.2017.02.020. Epub 2017 Mar 1. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 28259721 Review.
-
The use of intranasal oxytocin in the treatment of eating disorders.Neuropeptides. 2023 Dec;102:102387. doi: 10.1016/j.npep.2023.102387. Epub 2023 Oct 12. Neuropeptides. 2023. PMID: 37837804 Review.
-
Gender differences in eating disorder psychopathology across DSM-5 severity categories of anorexia nervosa and bulimia nervosa.Int J Eat Disord. 2018 Sep;51(9):1098-1102. doi: 10.1002/eat.22941. Epub 2018 Sep 7. Int J Eat Disord. 2018. PMID: 30193008 Free PMC article.
Cited by
-
Investigating resting brain perfusion abnormalities and disease target-engagement by intranasal oxytocin in women with bulimia nervosa and binge-eating disorder and healthy controls.Transl Psychiatry. 2020 Jun 8;10(1):180. doi: 10.1038/s41398-020-00871-w. Transl Psychiatry. 2020. PMID: 32513936 Free PMC article. Clinical Trial.
-
OXTR DNA methylation differentiates men on the obesity spectrum with and without binge eating disorder.Clin Epigenetics. 2022 Aug 30;14(1):108. doi: 10.1186/s13148-022-01318-3. Clin Epigenetics. 2022. PMID: 36042529 Free PMC article.
-
Oxytocin Pathway Gene (CD38, OXTR) Variants Are Not Related to Psychosocial Characteristics Defined by Strengths and Difficulties Questionnaire in Adolescents: A Field School-Based Study.Front Psychiatry. 2021 Aug 9;12:714093. doi: 10.3389/fpsyt.2021.714093. eCollection 2021. Front Psychiatry. 2021. PMID: 34434131 Free PMC article.
-
Peripheral Biomarkers of Anorexia Nervosa: A Meta-Analysis.Nutrients. 2024 Jun 30;16(13):2095. doi: 10.3390/nu16132095. Nutrients. 2024. PMID: 38999843 Free PMC article.
-
Low oxytocin levels are broadly associated with more pronounced psychopathology in anorexia nervosa with primarily restricting but not binge/purge eating behavior.Front Endocrinol (Lausanne). 2023 Jan 31;13:1049541. doi: 10.3389/fendo.2022.1049541. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36798485 Free PMC article.
References
-
- Iwasaki Y, Maejima Y, Suyama S, Yoshida M, Arai T, Katsurada K et al. Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: A route for ameliorating hyperphagia and obesity. Am J Physiol Regul Integr Comp Physiol. 2015;308(5):R360–9. doi:10.1152/ajpregu.00344.2014. - DOI - PubMed
-
- Gould BR, Zingg HH. Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor-LacZ reporter mouse. Neuroscience. 2003;122(1):155–67. - PubMed
-
- Peris J, MacFadyen K, Smith JA, de Kloet AD, Wang L, Krause EG. Oxytocin receptors are expressed on dopamine and glutamate neurons in the mouse ventral tegmental area that project to nucleus accumbens and other mesolimbic targets. J Comp Neurol. 2017;525(5):1094–108. doi:10.1002/cne.24116. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials